2025
SJR Q2
JCR Q3 · 2,9
35 matched articles
SCIE
Journal detail
Journal of Geriatric Oncology
- Publisher
- Elsevier Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1879406818794076
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,943
- Quartile Q2
- H-Index 63
- Cites/doc 2,34
- Docs (3y) 548
- Cites (3y) 1.456
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,9
- 5Y JIF 3
- JCI 0,62
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Geriatrics and Gerontology Q2
- Oncology Q2
Areas
- Medicine
WoS categories
- Oncology | Geriatrics & Gerontology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,943 | 2,9 | 3 | 0,62 | Q3 | 63 |
| 2024 | Q1 | Q3 | 1,36 | 2,7 | 2,8 | 0,65 | Q2 | 58 |
| 2023 | Q2 | Q2 | 1,052 | 3 | 2,9 | 0,71 | Q2 | 58 |
| 2022 | Q2 | Q3 | 1,025 | 3 | 3,2 | 0,71 | Q2 | 58 |
| 2021 | Q1 | Q3 | 1,364 | 3,9 | 4,1 | 0,76 | Q2 | 58 |
| 2020 | Q2 | Q3 | 1,032 | 3,6 | 4 | 0,7 | Q2 | 58 |
| 2019 | Q1 | Q3 | 1,428 | 2,8 | 3,2 | 0,78 | Q2 | 58 |
| 2018 | — | Q2 | — | 3,2 | 3,1 | 0,88 | Q2 | — |
| 2017 | Q1 | Q2 | 1,259 | 3,4 | 2,9 | 0,88 | Q2 | 58 |
| 2016 | Q1 | Q2 | 1,109 | 2,9 | 2,3 | — | — | 58 |
| 2015 | Q2 | Q3 | 1,084 | 2,3 | 2 | — | — | 58 |
| 2014 | Q1 | Q3 | 1,382 | 1,9 | 1,6 | — | — | 58 |
| 2013 | Q2 | Q3 | 0,617 | 1,1 | 1,1 | — | — | 58 |
| 2012 | Q2 | Q4 | 0,438 | 1,1 | 1,1 | — | — | 58 |
| 2011 | Q3 | Q4 | 0,354 | 1 | 1 | — | — | 58 |
| 2010 | — | — | — | — | — | — | — | 58 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | GERIATRICS & GERONTOLOGY | SCIE | Q3 | Q3 | 41/72 |
| 2025 | ONCOLOGY | SCIE | Q3 | Q3 | 175/333 |
| 2024 | GERIATRICS & GERONTOLOGY | SCIE | Q3 | Q3 | 39/73 |
| 2024 | ONCOLOGY | SCIE | Q3 | Q2 | 171/328 |
| 2023 | GERIATRICS & GERONTOLOGY | SCIE | Q3 | Q3 | 40/74 |
| 2023 | ONCOLOGY | SCIE | Q2 | Q2 | 142/322 |
| 2022 | GERIATRICS & GERONTOLOGY | SCIE | Q3 | Q3 | 35/54 |
| 2022 | ONCOLOGY | SCIE | Q3 | Q2 | 157/241 |
| 2021 | GERIATRICS & GERONTOLOGY | SCIE | Q3 | Q3 | 29/54 |
| 2021 | ONCOLOGY | SCIE | Q3 | Q2 | 138/245 |
| 2020 | GERIATRICS & GERONTOLOGY | SCIE | Q3 | Q3 | 30/53 |
| 2020 | ONCOLOGY | SCIE | Q3 | Q2 | 148/242 |
| 2019 | GERIATRICS & GERONTOLOGY | SCIE | Q3 | Q2 | 27/51 |
| 2019 | ONCOLOGY | SCIE | Q3 | Q2 | 154/244 |
| 2018 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | Q2 | 22/53 |
| 2018 | ONCOLOGY | SCIE | Q2 | Q2 | 107/230 |
| 2017 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | Q2 | 17/53 |
| 2017 | ONCOLOGY | SCIE | Q2 | Q2 | 103/223 |
| 2016 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 19/49 |
| 2016 | ONCOLOGY | SCIE | Q3 | — | 114/217 |
| 2015 | GERIATRICS & GERONTOLOGY | SCIE | Q3 | — | 25/49 |
| 2015 | ONCOLOGY | SCIE | Q3 | — | 139/213 |
| 2014 | GERIATRICS & GERONTOLOGY | SCIE | Q3 | — | 30/50 |
| 2014 | ONCOLOGY | SCIE | Q4 | — | 160/211 |
| 2013 | GERIATRICS & GERONTOLOGY | SCIE | Q3 | — | 36/49 |
| 2013 | ONCOLOGY | SCIE | Q4 | — | 175/203 |
| 2012 | GERIATRICS & GERONTOLOGY | SCIE | Q4 | — | 36/47 |
| 2012 | ONCOLOGY | SCIE | Q4 | — | 170/197 |
| 2011 | GERIATRICS & GERONTOLOGY | SCIE | Q4 | — | 36/45 |
| 2011 | ONCOLOGY | SCIE | Q4 | — | 165/196 |
| 2010 | GERIATRICS & GERONTOLOGY | SCIE | — | — | — |
| 2010 | ONCOLOGY | SCIE | — | — | — |